ATOSSA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ATOSSA THERAPEUTICS, INC. (ATOS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 90.53 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 90.53K shares, a 21.95% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was -1.41M shares.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 1.02M shares, a 115.87% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 158.48K shares, a 86.43% decline from fiscal 2024.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 1.17M shares, a 63.79% decline from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 3.22M shares, a 1511.94% increase from fiscal 2022.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 200.00K shares, a 25.00% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 90.53K shares 10-Q · filed 2026-08-07 | -1.32M shares derived: sum of 3 quarters · filed 2026-08-07 | -306.98K shares derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 90.53K shares 10-Q · filed 2026-05-08 | -1.32M shares derived: sum of 2 quarters · filed 2026-05-08 | -306.98K shares derived: sum of 3 quarters · filed 2026-05-08 | 133.02K shares derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | -1.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -397.52K shares derived: sum of 2 quarters · filed 2026-03-25 | 42.48K shares derived: sum of 3 quarters · filed 2026-03-25 | 158.48K shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 1.02M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 1.46M shares derived: sum of 2 quarters · filed 2025-11-12 | 1.57M shares 10-Q · filed 2025-11-12 | 1.57M shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 440.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 556.00K shares 10-Q · filed 2025-08-12 | 556.00K shares derived: sum of 3 quarters · filed 2025-08-12 | 1.03M shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 116.00K shares 10-Q · filed 2025-05-13 | 116.00K shares derived: sum of 2 quarters · filed 2025-05-13 | 587.00K shares derived: sum of 3 quarters · filed 2025-05-13 | 1.01M shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | 471.00K shares derived: sum of 2 quarters · filed 2025-03-25 | 898.18K shares derived: sum of 3 quarters · filed 2025-03-25 | 1.17M shares 10-K · filed 2025-03-25 |
| 2024-09-30 | 471.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 898.18K shares derived: sum of 2 quarters · filed 2024-11-12 | 1.17M shares 10-Q · filed 2024-11-12 | 3.97M shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 427.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 696.50K shares 10-Q · filed 2024-08-12 | 3.50M shares derived: sum of 3 quarters · filed 2024-08-12 | 3.50M shares derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | 269.32K shares 10-Q · filed 2024-05-13 | 3.07M shares derived: sum of 2 quarters · filed 2024-05-13 | 3.07M shares derived: sum of 3 quarters · filed 2024-05-13 | 3.49M shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | 2.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 2.80M shares derived: sum of 2 quarters · filed 2024-04-01 | 3.22M shares derived: sum of 3 quarters · filed 2024-04-01 | 3.22M shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 419.00K shares derived: sum of 2 quarters · filed 2023-11-13 | 419.00K shares 10-Q · filed 2023-11-13 | 419.00K shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | 419.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 419.00K shares 10-Q · filed 2023-08-14 | 419.00K shares derived: sum of 3 quarters · filed 2023-08-14 | 619.00K shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2023-05-15 | 200.00K shares derived: sum of 3 quarters · filed 2023-05-15 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 200.00K shares derived: sum of 2 quarters · filed 2023-03-22 | 200.00K shares 10-K · filed 2023-03-22 | |
| 2022-09-30 | 200.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | 200.00K shares 10-Q · filed 2022-11-07 | ||
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-08 | |||
| 2021-12-31 | 85.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 85.00K shares derived: sum of 2 quarters · filed 2022-02-28 | 160.00K shares 10-K · filed 2022-02-28 | |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 75.00K shares 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | 75.00K shares 10-Q · filed 2021-08-13 | |||
| 2020-12-31 | 12.39K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 155.95K shares 10-K · filed 2021-03-31 | ||
| 2020-09-30 | 143.55K shares 10-Q · filed 2020-11-13 | |||
| 2018-06-30 | 338.00 shares 10-Q/A · filed 2018-11-13 | |||
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | 0.00 shares derived: sum of 2 quarters · filed 2018-03-08 | 0.00 shares derived: sum of 3 quarters · filed 2018-03-08 | 3.17K shares 10-K · filed 2018-03-08 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2017-11-13 | 3.17K shares 10-Q · filed 2017-11-13 | 14.67K shares derived: sum of 4 quarters · filed 2017-11-13 |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 3.17K shares 10-Q · filed 2017-08-14 | 14.67K shares derived: sum of 3 quarters · filed 2017-08-14 | -430.84K shares derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | 3.17K shares 10-Q · filed 2017-05-11 | 14.67K shares derived: sum of 2 quarters · filed 2017-05-11 | -430.84K shares derived: sum of 3 quarters · filed 2017-05-11 | -361.81K shares derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | 11.50K shares derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | -434.00K shares derived: sum of 2 quarters · filed 2017-03-21 | -364.97K shares derived: sum of 3 quarters · filed 2017-03-21 | 47.25K shares 10-K/A · filed 2017-03-21 |
| 2016-09-30 | -445.50K shares derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21 | -376.47K shares derived: sum of 2 quarters · filed 2017-03-21 | 35.75K shares 10-Q/A · filed 2017-03-21 | 1.03M shares derived: sum of 4 quarters · filed 2017-03-21 |
| 2016-06-30 | 69.03K shares derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-03-21 | 481.26K shares 10-Q/A · filed 2017-03-21 | 1.48M shares derived: sum of 3 quarters · filed 2017-03-21 | 1.53M shares derived: sum of 4 quarters · filed 2017-03-21 |
| 2016-03-31 | 412.22K shares 10-Q/A · filed 2017-03-21 | 1.41M shares derived: sum of 2 quarters · filed 2017-03-21 | 1.46M shares derived: sum of 3 quarters · filed 2017-03-21 | 1.88M shares derived: sum of 4 quarters · filed 2017-03-21 |
| 2015-12-31 | 998.47K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 1.05M shares derived: sum of 2 quarters · filed 2016-03-30 | 1.47M shares derived: sum of 3 quarters · filed 2016-03-30 | 1.56M shares 10-K · filed 2016-03-30 |
| 2015-09-30 | 50.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 469.51K shares derived: sum of 2 quarters · filed 2015-11-12 | 559.05K shares 10-Q · filed 2015-11-12 | 692.64K shares derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-06-30 | 419.51K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 509.05K shares 10-Q · filed 2015-08-06 | 642.64K shares derived: sum of 3 quarters · filed 2015-08-06 | 1.31M shares derived: sum of 4 quarters · filed 2015-08-06 |
| 2015-03-31 | 89.54K shares 10-Q · filed 2015-05-13 | 223.14K shares derived: sum of 2 quarters · filed 2015-05-13 | 894.06K shares derived: sum of 3 quarters · filed 2015-05-13 | 902.07K shares derived: sum of 4 quarters · filed 2015-05-13 |
| 2014-12-31 | 133.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | 804.52K shares derived: sum of 2 quarters · filed 2015-03-30 | 812.53K shares derived: sum of 3 quarters · filed 2015-03-30 | 873.75K shares 10-K · filed 2015-03-30 |
| 2014-09-30 | 670.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | 678.93K shares derived: sum of 2 quarters · filed 2014-11-12 | 740.16K shares 10-Q · filed 2014-11-12 | 788.47K shares derived: sum of 4 quarters · filed 2014-11-12 |
| 2014-06-30 | 8.02K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | 69.24K shares 10-Q · filed 2014-08-12 | 117.55K shares derived: sum of 3 quarters · filed 2014-08-12 | 326.36K shares derived: sum of 4 quarters · filed 2014-08-12 |
| 2014-03-31 | 61.22K shares 10-Q · filed 2014-05-14 | 109.53K shares derived: sum of 2 quarters · filed 2014-05-14 | 318.34K shares derived: sum of 3 quarters · filed 2014-05-14 | 328.38K shares derived: sum of 4 quarters · filed 2014-05-14 |
| 2013-12-31 | 48.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | 257.12K shares derived: sum of 2 quarters · filed 2014-03-27 | 267.16K shares derived: sum of 3 quarters · filed 2014-03-27 | 269.83K shares 10-K · filed 2014-03-27 |
| 2013-09-30 | 208.81K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 218.85K shares derived: sum of 2 quarters · filed 2013-11-12 | 221.52K shares 10-Q · filed 2013-11-12 | 225.14K shares derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-06-30 | 10.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | 12.71K shares 10-Q · filed 2013-08-14 | 16.33K shares derived: sum of 3 quarters · filed 2013-08-14 | |
| 2013-03-31 | 2.67K shares 10-Q · filed 2013-05-15 | 6.29K shares derived: sum of 2 quarters · filed 2013-05-15 | ||
| 2012-12-31 | 3.62K shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | 3.62K shares 10-K · filed 2013-03-28 | ||
| 2012-09-30 | 0.00 shares 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |